Unknown

Dataset Information

0

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft.


ABSTRACT: Islet transplantation to treat the late stage of type 1 diabetic patient (T1DM) has recently made inspiring success in clinical trials. However, most patients experience a decline in islet graft function in one to three years due to immune rejection. Although the mechanisms of immune cells, including macrophages, dendritic cells (DCs), neutrophils, natural killer cells (NKs), B cells, and T cells, that mediate immune rejection have been investigated, the overall characteristics of immune infiltrates in islet allografts and syngeneic grafts remain unclear. Single-cell RNA sequencing (scRNA-seq) has provided us with new opportunities to study the complexity of the immune microenvironment in islet transplants. In the present study, we used scRNA-seq to comprehensively analyze the immune heterogeneity in the mouse model of islet transplantation. Our data revealed T lymphocytes and myeloid cells as the main immune components of grafts 7 days post-islet transplantation, especially in allografts. Moreover, our results indicated that allogeneic islet cells were transformed into antigen-presenting cell-like cells with highly expressed MHC class I molecules and genes involved in MHC class I-mediated antigen presentation. This transformation may dramatically facilitate the interaction with cytotoxic CD8+ T cells and promote the destruction of islet allografts. Our study provides insight into the transcriptomics and diverse microenvironment of islet grafts and their impacts on immune rejection.

SUBMITTER: Chen P 

PROVIDER: S-EPMC9226584 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft.

Chen Pengfei P   Yao Fuwen F   Lu Ying Y   Peng Yuanzheng Y   Zhu Shufang S   Deng Jing J   Wu Zijing Z   Chen Jiao J   Deng Kai K   Li Qi Q   Pu Zuhui Z   Mou Lisha L  

Frontiers in immunology 20220610


Islet transplantation to treat the late stage of type 1 diabetic patient (T1DM) has recently made inspiring success in clinical trials. However, most patients experience a decline in islet graft function in one to three years due to immune rejection. Although the mechanisms of immune cells, including macrophages, dendritic cells (DCs), neutrophils, natural killer cells (NKs), B cells, and T cells, that mediate immune rejection have been investigated, the overall characteristics of immune infiltr  ...[more]

Similar Datasets

| S-EPMC8866760 | biostudies-literature
| S-EPMC9210310 | biostudies-literature
| S-EPMC2927944 | biostudies-literature
| S-EPMC10255004 | biostudies-literature
| S-EPMC10658307 | biostudies-literature
| S-EPMC5495486 | biostudies-literature
| S-EPMC9328940 | biostudies-literature
| S-EPMC4708880 | biostudies-literature
| S-EPMC2948074 | biostudies-literature
| S-EPMC10174692 | biostudies-literature